Hot topics in
multiple sclerosis

First triMS.online conference, November 2018

  • The latest research and clinical insights on the theme Progressive MS: is PPMS modifiable?
  • A ‘hot topic’ debate on the motion ‘We should routinely monitor cognition in standard MS clinical practice’

NovartisRoche

Current concepts in
paediatric MS

Second triMS.online conference, June 2019

  • The latest research and clinical insights on the theme Current concepts in paediatric MS
  • An expert panel discussion on a current controversy ‘Clinical trials in paediatric MS should be conducted for study drugs with established efficacy in adult MS’

Novartis

Management challenges in MS: immunology

Third triMS.online conference, February 2020

  • The latest research and clinical insights on Management challenges in MS: immunology
  • 'Hot topic' debate on the motion ‘Anti-viral drug prophylaxis should be given routinely to patients with MS who have grade 3 or 4 lymphopenia’

Looking ahead: the future of MS management

The fourth triMS.online conference, October 2020

The latest research and clinical insights on Looking ahead: the future of MS management

Themed sessions across two days

  • Day 1 – Tailoring MS treatment in the face of COVID-19
  • Day 2 – Current and emerging treatments for MS

'Hot topic' debates on the topics:

  • COVID-19 will improve the future management of patients with MS
  • Should patients with MS be vaccinated against
    COVID-19?
  • Can we use anti-CD20 therapies as immune reconstitution therapies rather than maintenance therapies?